Inform Diagnostics (MLS), the leading pathology services provider that
collaborates to make patients and practices better, announced today that
it will have a significant presence at the Annual Meeting for the American
Society of Hematology (ASH), a conference offering roundtable discussions,
hands-on training and health policy updates, on December 7-10 in New Orleans,
Visitors to MLS’ booth can learn important information about forthcoming
regulatory guidance and compliance. MLS technical directors will be available
to help ASH attendees avoid potential penalties in 2014 and successfully
attest to Meaningful Use requirements. MLS technical directors can also
help attendees prepare for Meaningful Use audits by ensuring adherence
to CMS requirements and prepare for the revolution in medical billing, ICD10.
ASH holds an annual meeting every winter to provide opportunities to grow
professionally by learning about the latest clinical updates in research,
therapies, and practice strategies through Education and Scientific Programs.
In 2013, ASH will showcase the full spectrum of translation in hematology
from new basic research to new insights into disease pathogenesis to new
therapies for patients to outcome analyses. Networking events allow attendees
to connect with more than 20,000 colleagues from around the globe to learn
and share ideas.
The 55th Annual Meeting will be held at the Ernest N. Morial Convention
Center in New Orleans, Louisiana.
About Inform Diagnostics
Serving more than 3,500 patients each day,
Inform Diagnostics is a leader in providing an academic-caliber pathology laboratory with
diagnostic services in the fields of dermatology, gastroenterology, hematology
and urology. Building upon our experience with health IT, we also offer
accessible technology solutions to assist healthcare professionals as
they work towards accordance with Meaningful Use initiatives.
Inform Diagnostics, a wholly-owned subsidiary of Japan-based Inform Diagnostics Holdings
Inc., employs a talented team of leading pathologists, histologists, lab
technicians, technology consultants, and other medical professionals —
all driven to help provide the highest and most up-to-date levels of diagnostic
quality, enhanced workflow and practice solutions possible. It is part
of our commitment: not only to scientific excellence, but to patients
The American Society of Hematology (ASH) is the world’s largest
professional society concerned with the causes and treatments of blood
disorders. The mission of the Society is to further the understanding,
diagnosis, treatment, and prevention of disorders affecting the blood,
bone marrow, and the immunologic, hemostatic and vascular systems, by
promoting research, clinical care, education, training, and advocacy in